-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, February 2026
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Thematic Analysis
Precision and Personalized Medicine - Advanced Therapeutics: Strategic Intelligence
Precision and personalized medicine (PPM) has already begun to reshape disease treatment paradigms and the provision of healthcare. Gene-modified cell therapies are emerging as a cornerstone modality within PPM. Cell therapies are entering a rapid growth phase across oncology and regenerative medicine. Gene therapy remains a blockbuster-led modality with expanding therapeutic reach. Antisense oligonucleotides are emerging as a fast-growing modality within PPM. Oncolytic virus therapies show emerging commercial traction but remain a niche modality. Core precision medicine enablers are strengthening...
-
Product Insights
Human Immunodeficiency Virus (HIV) Infections (AIDS): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Human Immunodeficiency Virus (HIV) Infections (AIDS) - Global Clinical Trials Review, 2026" provides an overview of Human Immunodeficiency Virus (HIV) Infections (AIDS) Clinical trials scenario. This report provides top line data relating to the clinical trials on Human Immunodeficiency Virus (HIV) Infections (AIDS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Hepatitis B: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Hepatitis B - Global Clinical Trials Review, 2026" provides an overview of Hepatitis B Clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis B. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) - Global Clinical Trials Review, 2026" provides an overview of Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Product Insights
Psoriatic Arthritis: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Psoriatic Arthritis - Global Clinical Trials Review, 2026" provides an overview of Psoriatic Arthritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriatic Arthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Hyperlipidemia: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Hyperlipidemia - Global Clinical Trials Review, 2026" provides an overview of Hyperlipidemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperlipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hyperthyroidism: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Hyperthyroidism - Global Clinical Trials Review, 2026" provides an overview of Hyperthyroidism Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperthyroidism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Crohn's Disease (Regional Enteritis): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2026" provides an overview of Crohn's Disease (Regional Enteritis) Clinical trials scenario. This report provides top line data relating to the clinical trials on Crohn's Disease (Regional Enteritis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Global Clinical Trials Review, 2026" provides an overview of Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Clinical trials scenario. This report provides top line data relating to the clinical trials on Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.